SCHEMBL1822940

SCHEMBL1822940

OCCNCc1ccc(O)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.56
PDCD1 Q15116 1/20 0.53
CD274 Q9NZQ7 1/20 0.53
CA2 P00918 3/20 0.50
CA1 P00915 2/20 0.50
ALDH1A1 P00352 1/20 0.50
TSHR P16473 1/20 0.50
DRD4 P21917 1/20 0.49
SCN8A Q9UQD0 1/20 0.47
BCHE P06276 1/20 0.47
GSR P00390 2/20 0.47
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
TDP1 Q9NUW8 1/20 0.44
ESR1 P03372 2/20 0.44
ESR2 Q92731 2/20 0.44
TMEM97 Q5BJF2 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
CHEK1 O14757 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1625535 0.91 SMN1; SMN2 (0.64) SMN1; SMN2PDCD1CD274ALDH1A1TSHR
SCHEMBL11592004 0.88 MEN1 (0.56) SMN1; SMN2CA2CA1ALDH1A1DRD4
SCHEMBL6277988 0.83 CA2 (0.61) CA2CA1ALDH1A1DRD4SCN8A
SCHEMBL11594250 0.82 MAOA (0.61) SCN8ASIGMAR1
SCHEMBL29017807 0.80 CA2 (0.60) CA2CA1ALDH1A1BCHEKMT2A
SCHEMBL8252697 0.80 L3MBTL1 (0.56) SMN1; SMN2PDCD1CD274ALDH1A1TSHR
SCHEMBL3622998 0.80 HRH4 (0.52) SMN1; SMN2CA2CA1ALDH1A1DRD4
SCHEMBL6081998 0.80 SMN1; SMN2 (0.55) SMN1; SMN2PDCD1CD274ALDH1A1TSHR
SCHEMBL2263025 0.80 CHRM2 (0.64) SMN1; SMN2PDCD1CD274CA2CA1
SCHEMBL5853981 0.80 CYP1A2 (0.56) SMN1; SMN2PDCD1CD274CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3758737-A1 IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF Kodiak Sciences Inc. (US) 2021-01-06 EP disclosed
CN-102585844-B Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element containing same CHI MEI CORP 2014-03-12 CN disclosed
US-8455692-B2 Process for resolution of 1-(3-hydroxyphenyl)-2-methylamino ethanol Divi's Laboratories, Ltd. (IN) 2013-06-04 US disclosed
CN-102585844-A Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element containing same CHI MEI CORP 2012-07-18 CN disclosed
US-20120108848-A1 PROCESS FOR RESOLUTION OF 1-(3-HYDROXYPHENYL)-2-METHYLAMINO ETHANOL DIVI'S LABORATORIES LIMITED (IN) 2012-05-03 US disclosed
EP-2315615-A2 METHODS AND KITS FOR PERMANENTLY COLORING HAIR USING PERSULFATES, PERBORATES OR PERCARBONATES L'Oréal (FR) 2011-05-04 EP disclosed
WO-2010023560-A2 METHODS AND KITS FOR PROVIDING LIFT AND THEN A PERMANENT COLOR TO HAIR L'OREAL (FR) 2010-03-04 WO disclosed
WO-2010011599-A2 PIMETHIXENE DERIVATIVES FOR PROMOTING BONE GROWTH OSTEOGENEX INC. (US) 2010-01-28 WO disclosed
WO-2009148874-A2 GAMMA-LACTAM COMPOUNDS FOR PROMOTING BONE GROWTH OSTEOGENEX INC. (US) 2009-12-10 WO disclosed
US-7589127-B2 Aminoalkylphenols, methods of using and making the same MERCK & CO., INC. (US) 2009-09-15 US disclosed
US-20040122782-A1 Process for determining the composition of a dye product L'OREAL (FR) 2004-06-24 US disclosed
CN-1426777-A Composition for oxidation dyeing of keratin fibre and method for dyeing keratin fibre OREAL (FR) 2003-07-02 CN disclosed
US-6004669-A ELECTROSTATIC CHARGING MEMBER, UNIFORMLY DISPERSED IN A MODIFIED RESIN AS A BASE POLYMER BEING MODIFIED BY AN AMINE GROUP WHICH HAS AN ACID-BASE INTERACTION WITH THE OXIDATION-PROCESSED ELECTRICALLY-CONDUCTING AGENT, FUJI XEROX CO., LTD. (JP) 1999-12-21 US disclosed
US-5852071-A Biphenyl additive for improvement in urethane foundry binders BORDEN CHEMICAL, INC. (US) 1998-12-22 US disclosed
EP-0863927-A1 RAPID-FOAMING FOAM FOR PREFABRICATED SYSTEM BUILDING RATHOR AG (CH) 1998-09-16 EP disclosed
US-5792802-A IMPROVEMENTS IN HUMIDITY RESISTANCE, MOLD RELEASE AND HOT STRENGTH BORDEN CHEMICAL, INC. (US) 1998-08-11 US disclosed
US-5744518-A Biphenyl additive for improvement in urethane foundry binders BORDEN CHEMICAL, INC. (US) 1998-04-28 US disclosed
WO-1997020876-A1 RAPID-FOAMING FOAM FOR PREFABRICATED SYSTEM BUILDING RATHOR AG (CH) 1997-06-12 WO disclosed
EP-0695594-A2 Biphenyl additive for improvement in urethane foundry binders Borden, Inc. (US) 1996-02-07 EP disclosed
CN-87101828-A BROMINE-CONTAINING POLYOLS 1987-11-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108848-A1 PROCESS FOR RESOLUTION OF 1-(3-HYDROXYPHENYL)-2-METHYLAMINO ETHANOL ADH1A, CYP2E1, ADH1C SMN1; SMN2 2620/4885PDCD1 4727/4885CD274 4726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.